Search research articles
Contact Us
Filters
Showing results (231-240 of 329) with videos related to
Page
of 33
Sort By:
Frontiers in Psychiatry
|
August 29, 2022
The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A <sup>1</sup>H-MRS study in first-episode psychosis patients
Uzma Zahid, Robert A McCutcheon, Faith Borgan, et al.
Human Molecular Genetics
|
June 27, 2018
The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study
Tarik Dahoun, Antonio F Pardiñas, Mattia Veronese, et al.
Psychopharmacology
|
December 29, 2012
The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole
Euitae Kim, Oliver D Howes, Federico E Turkheimer, et al.
Archives of General Psychiatry
|
January 7, 2009
Elevated striatal dopamine function linked to prodromal signs of schizophrenia
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, et al.
The Lancet. Psychiatry
|
September 29, 2023
Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development
Toby Pillinger, Oliver D Howes, Christoph U Correll, et al.
The American Journal of Psychiatry
|
October 17, 2015
Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study
Peter S Bloomfield, Sudhakar Selvaraj, Mattia Veronese, et al.
Schizophrenia Research
|
June 14, 2022
Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capacity
Matthew J Reid, Maria Rogdaki, Lucia Dutan, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 7, 2020
The acute effects of cannabidiol on the neural correlates of reward anticipation and feedback in healthy volunteers
Will Lawn, James Hill, Chandni Hindocha, et al.
Molecular Imaging and Biology
|
April 3, 2024
Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study
Alice Petty, Anna Garcia-Hidalgo, Els F Halff, et al.
Molecular Imaging and Biology
|
October 23, 2023
Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study
Alice Petty, Anna Garcia-Hidalgo, Els F Halff, et al.
Page
of 33
Search research articles
Search
Showing results (231-240 of 329) with videos related to
Sort By:
Page
of 33
Frontiers in Psychiatry
|
August 29, 2022
The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A <sup>1</sup>H-MRS study in first-episode psychosis patients
Uzma Zahid, Robert A McCutcheon, Faith Borgan, et al.
Human Molecular Genetics
|
June 27, 2018
The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study
Tarik Dahoun, Antonio F Pardiñas, Mattia Veronese, et al.
Psychopharmacology
|
December 29, 2012
The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole
Euitae Kim, Oliver D Howes, Federico E Turkheimer, et al.
Archives of General Psychiatry
|
January 7, 2009
Elevated striatal dopamine function linked to prodromal signs of schizophrenia
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, et al.
The Lancet. Psychiatry
|
September 29, 2023
Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development
Toby Pillinger, Oliver D Howes, Christoph U Correll, et al.
The American Journal of Psychiatry
|
October 17, 2015
Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study
Peter S Bloomfield, Sudhakar Selvaraj, Mattia Veronese, et al.
Schizophrenia Research
|
June 14, 2022
Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capacity
Matthew J Reid, Maria Rogdaki, Lucia Dutan, et al.
Journal of Psychopharmacology (Oxford, England)
|
August 7, 2020
The acute effects of cannabidiol on the neural correlates of reward anticipation and feedback in healthy volunteers
Will Lawn, James Hill, Chandni Hindocha, et al.
Molecular Imaging and Biology
|
April 3, 2024
Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study
Alice Petty, Anna Garcia-Hidalgo, Els F Halff, et al.
Molecular Imaging and Biology
|
October 23, 2023
Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study
Alice Petty, Anna Garcia-Hidalgo, Els F Halff, et al.
Page
of 33